Airsculpt Technologies, Inc. (AIRS)

In the past six months, AirSculpt Technologies' stock has been impacted by several key events. Michael Doyle was elected as a Class III director and Non-Executive Chairman of the Board, and Michael Arthur was appointed Chief Financial Officer. AirSculpt Technologies announced it would be unable to file its annual 10-K by the SEC deadline. The company reported its fourth-quarter and full-year fiscal 2025 results, with preliminary fiscal year 2025 revenue approximately $151.8 million, a 15.8% decrease year-over-year, with same-store revenue down approximately 16% in Q4 2025, but management noted sequential improvement, with same-store sales turning positive in February 2026. Major shareholder Jorey Chernett made several purchases of AIRS stock in March and April 2026. AirSculpt Technologies reported Q1 fiscal 2026 results, with revenue of $39.4 million, flat year-over-year, and the first positive same-center sales in over two years, and reaffirmed its full-year 2026 revenue guidance.

The second quarter (Q2) is generally considered a seasonally stronger quarter for AirSculpt Technologies' products and services. The company anticipates sequential improvement in both revenue and EBITDA in Q2.

AirSculpt Technologies, Inc. operates as a holding company for EBS Intermediate Parent LLC, providing body contouring procedure services primarily in the United States and Canada. The company specializes in minimally invasive body contouring using its proprietary AirSculpt® technology, which removes fat and tightens skin without the need for scalpels, stitches, or general anesthesia. Its major products and services include AirSculpt® for fat removal and skin tightening, AirSculpt+ combining fat removal with Renuvion® technology, AirSculpt Smooth for cellulite removal, fat removal procedures targeting areas like the stomach and back, and fat transfer procedures enhancing areas like the buttocks or breasts.

AirSculpt Technologies operates a network of clinics across the United States, Canada, and the United Kingdom. As of December 2024 and March 2025, the company had 32 locations across North America. Specific markets in North America include Sacramento, Beverly Hills, Orlando, Houston, Seattle, Denver, Charlotte, Las Vegas, Boston, Philadelphia, New York City, Toronto, Chicago, San Diego, Dallas, Washington, D.C., Minneapolis, Salt Lake City, Atlanta, Phoenix, Miami, Nashville, Austin, Orange County, Raleigh, San Jose, Kansas City, Columbus, Deerfield (IL), Birmingham (MI), and White Plains (NY). The company's headquarters are located in Miami Beach, Florida.

In February 2024, a report alleged that AirSculpt lies about safety, employs suspect doctors, makes misleading technology claims, and uses fake reviews and false advertising. In response to challenging market conditions and to improve demand, AirSculpt Technologies has implemented an enhanced marketing strategy starting in Q4 2025, including an expanded media mix, Connected TV, increased influencer engagement, and more targeted campaigns, alongside improvements to their digital funnel and website.

AirSculpt Technologies, Inc. is predominantly owned by institutional investors. As of May 6, 2026, 103 institutional owners held a total of 42,674,428 shares. Major institutional shareholders include Vesey Street Capital Partners, L.L.C., Balyasny Asset Management Llc, Vanguard Group Inc, Renaissance Technologies Llc, BlackRock, Inc., Susquehanna International Group, Llp, Wexford Capital Lp, National Bank Of Canada /fi/, and FourWorld Capital Management LLC. Vesey Street Capital Partners, L.L.C. is noted as the largest institutional shareholder. Individual investors, such as major shareholder Jorey Chernett, have also significantly increased their holdings through open-market purchases.